癌の生存率を向上させるための世界的な優先事項
Henry C Y Wong1, Nicolas H Hart2,3, Alexandre Chan4,5
1Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong S.A.R., China.
Current opinion in oncology
|February 18, 2026
まとめ
世界的にがん生存者のケアを改善するには,平等なアクセスと多様な患者のニーズに焦点を当てることが必要です. 多分野チームと技術主導の介入の実施は,世界的により良い結果を出すために不可欠です.
科学分野:
- 腫瘍学 腫瘍学
- 公衆衛生は公衆衛生である.
- 医療サービス 研究 医療サービス
背景:
- 癌の生存率は,がん治療の焦点となっているが,質の高いサービスへのアクセスは,世界的に不均等である.
- 生存者の必要性は,がんのタイプと患者の人口統計学に基づいて大きく異なるが,高齢者や進行した疾患を持つ患者も含まれている.
研究 の 目的:
- グローバルながん生存者ケアを強化するための主要な優先事項を特定する.
- アクセスにおける格差,脆弱なグループの成果,および新しいケアモデルの統合に対処するためです.
主な方法:
- このレビューは,がん生存者ケアにおける課題と解決策に関する現在の知識をまとめています.
- 多分野チーム,デジタル・ヘルス,人工知能の役割を考察しています.
- IPOSやMASCCなどの国際機関の調査結果を考慮したものです.
主要な成果:
- がんを生き延びた人は,特に高齢者や進行した癌を患っている人は,ユニークな課題に直面しています.
- 多学科ケアモデルは生活の質を向上させ,費用を削減しますが,腫瘍科医によるフォローアップは依然として優位です.
- デジタルヘルスとAIは,強化されたモニタリングとパーソナライズされたケアのための可能性を秘めています.
- 支援ケアへのアクセスとガイドラインの実施における大きな格差は,特に低所得国や中所得国で,依然として残っています.
結論:
- 生存者介護の進歩は,研究と政策に公平性を組み込むことを必要としています.
- グローバルコラボレーションと並行して,多分野および技術ベースのモデルを拡大することが不可欠です.
- 長期的研究,適応ガイドライン,資源の限られた環境での能力構築は,生存者の結果を最適化するために不可欠です.
関連する概念動画
Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Cancer Prevention
8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
8.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Cancer Vaccines
1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K

